Skip to main content

Home/ PharmaMics/ Group items tagged #ovariancancer

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
ramchintamaneni

ESMO 2019: ImmunoGen's ovarian cancer drug fails to meet PFS - 0 views

www.clinicaltrialsarena.com/...esmo-immunogen

#esmo2019 #esmocongress #esmoconference #ovariancancer #medicalnews #medicalindustry

shared by ramchintamaneni on 07 Oct 19 - No Cached
  • ramchintamaneni on 07 Oct 19
     
    ImmunoGen has presented full data from Phase 3 Forward I study of Mirvetuximab Soravtansine in ovarian cancer at the ESMO 2019 Congress in Barcelona, Spain.
1 - 1 of 1
Showing 20▼ items per page